Physician profile
Joseph Watson
NPI 1174633317
$15,823.95
in general payments reported to CMS, 2019-2025
25 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $222 · 2021: $282 · 2022: $14K · 2023: $313 · 2024: $300 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,228.85 | 2022-2023 | Da Vinci Surgical System |
| Abbvie INC. | $376.64 | 2019-2025 | |
| Pfizer INC. | $186.44 | 2019-2023 | |
| Caldera Medical, INC | $154.44 | 2024 | Desara |
| Hologic Sales and Service, LLC | $135.78 | 2021-2025 | Thinprep 2000 Processor, Aptima, Fetal Fibronectin Enzyme Immunoassay |
| Astellas Pharma US INC | $102.27 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $76.20 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $65.12 | 2022 | |
| Exeltis, USA INC. | $62.07 | 2020-2025 | Slynd |
| Glaxosmithkline, LLC. | $51.01 | 2020 | |
| Shield Therapeutics INC | $39.58 | 2023-2024 | Accrufer |
| Avion Pharmaceuticals | $37.92 | 2021-2023 | Balcoltra |
| Merck Sharp & Dohme LLC | $36.98 | 2023 | Gardasil 9 |
| Organon LLC | $35.15 | 2022-2024 | |
| Myovant Sciences INC. | $30.15 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $30.00 | 2019-2021 | |
| Biom'Up Sa | $25.86 | 2019 | |
| Agile Therapeutics, INC. | $22.71 | 2022 | |
| Conmed Corporation | $22.18 | 2022 | |
| Sage Therapeutics, LLC | $21.87 | 2024 | |
| Therapeuticsmd, INC. | $21.54 | 2020 | |
| Optumhealth Care Solutions, LLC | $20.65 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Boston Scientific Corporation | $13.88 | 2023 | Wavewriter Alpha Prime 16 |
| Coloplast Corp | $13.39 | 2019 | |
| Sumitomo Pharma America, INC. | $13.27 | 2023 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.